VIR COMBINATION (influenzinum- 2019-2020, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvi United States - English - NLM (National Library of Medicine)

vir combination (influenzinum- 2019-2020, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvi

deseret biologicals, inc. - influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) antigen (formaldehyde inactivated) (unii: xw4jb03ti5) (influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:92xe6ghc89), influenza a virus a/kansas/14/2017 x-327 (h3n2) antigen (formaldehyde inactivated) (unii: 3nzw5nd3d6) (influenza a virus a/kansas/14/2017 x-327 (h3n2) antigen (formaldehyde inactivated) - unii:3nzw5nd3d6), influenza b virus b/maryland/15/2016 antigen (formaldehyde inactivated) (uni - for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

VIR COMBINATION (influenzinum- 2020-2021, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvi United States - English - NLM (National Library of Medicine)

vir combination (influenzinum- 2020-2021, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvi

deseret biologicals, inc. - influenza a virus a/guangdong-maonan/swl1536/2019 cnic-1909 (h1n1) antigen (formaldehyde inactivated) (unii: ny1ff92m1e) (influenza a virus a/guangdong-maonan/swl1536/2019 cnic-1909 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:r0bt251sa5), influenza a virus a/hong kong/2671/2019 ivr-208 (h3n2) antigen (formaldehyde inactivated) (unii: p8orn3uom6) (influenza a virus a/hong kong/2671/2019 ivr-208 (h3n2) hemagglutinin antigen (formaldehyde inactivated) - unii:thg3pu0kok), influenza b virus - for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

VIR COMBINATION (influenzinum- 2021-2022, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvi United States - English - NLM (National Library of Medicine)

vir combination (influenzinum- 2021-2022, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvi

deseret biologicals, inc. - influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (formaldehyde inactivated) (unii: wd5e5vym2e) (influenza a virus a/victoria/361/2011 ivr-165 (h3n2) hemagglutinin antigen (formaldehyde inactivated) - unii:w762brg698), influenza a virus a/tasmania/503/2020 ivr-221 (h3n2) antigen (formaldehyde inactivated) (unii: v529ejb2cx) (influenza a virus a/tasmania/503/2020 ivr-221 (h3n2) hemagglutinin antigen (formaldehyde inactivated) - unii:cyn792b8tr), influenza b virus b/washington/02/2019 antigen (f - for temporary relief of symptoms related to general viral infection, including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Cytomegalovirus (Human herpesvirus 5) IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

cytomegalovirus (human herpesvirus 5) ivds

diasorin australia pty ltd - ct748 - cytomegalovirus (human herpesvirus 5) ivds - for the in vitro quantitation of cytomegalovirus (cmv) nucleic acids in whole blood and plasma specimens. for use on the integrated cycler instrument.

Cytomegalovirus (Human herpesvirus 5) IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

cytomegalovirus (human herpesvirus 5) ivds

diasorin australia pty ltd - ct748 - cytomegalovirus (human herpesvirus 5) ivds - for in vitro diagnostic use in testing to provide information about infection with or exposure to cytomegalovirus (cmv).

Cytomegalovirus (Human herpesvirus 5) IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

cytomegalovirus (human herpesvirus 5) ivds

biomerieux australia pty ltd - ct748 - cytomegalovirus (human herpesvirus 5) ivds - ivds that are intended to be used in testing to provide information about infection with or exposure to cytomegalovirus (cmv).

Cytomegalovirus (Human herpesvirus 5) IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

cytomegalovirus (human herpesvirus 5) ivds

siemens healthcare pty ltd - ct748 - cytomegalovirus (human herpesvirus 5) ivds - for in vitro diagnostic use in testing to provide information about infection with, or exposure to, cytomegalovirus (cmv).

Epstein-Barr virus (Human herpesvirus 4) IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

epstein-barr virus (human herpesvirus 4) ivds

biomerieux australia pty ltd - ct747 - epstein-barr virus (human herpesvirus 4) ivds - ivds intended to be used in testing to provide information about infection with or exposure to epstein-barr virus (ebv).

Herpes simplex virus (HSV) (Human herpesvirus 1 & 2) IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

herpes simplex virus (hsv) (human herpesvirus 1 & 2) ivds

becton dickinson pty ltd - ct749 - herpes simplex virus (hsv) (human herpesvirus 1 & 2) ivds - the bd probetec? herpes simplex viruses (hsv 1 & 2) qx amplified dna assays (hsv qx assays), when tested with the bd viper? system in extracted mode, use strand displacement amplification technology for the direct, qualitative detection and differentiation of herpes simplex virus type 1 (hsv1) and herpes simplex virus type 2 (hsv2) dna in clinician-collected external anogenital lesion specimens. the assays are indicated for use with symptomatic individuals to aid in the diagnosis of anogenital hsv1 and hsv2 infections. the control set for the bd probetec? herpes simplex viruses (hsv 1 & 2) qx amplified dna assays contains positive and negative controls that are intended for quality control use with the bd probetec? herpes simplex viruses (hsv 1 & 2) qx amplified dna assays (hsv qx assays) when tested with the bd viper? system in extracted mode.

Herpes simplex virus (HSV) (Human herpesvirus 1 & 2) IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

herpes simplex virus (hsv) (human herpesvirus 1 & 2) ivds

diasorin australia pty ltd - ct749 - herpes simplex virus (hsv) (human herpesvirus 1 & 2) ivds - for in vitro diagnostic use in testing to provide information about infection with or exposure to herpes simplex virus 1 (hsv1) and/or herpes simplex virus 2 (hsv2).